|
|
|
Volumn 37, Issue 2, 2005, Pages 102-107
|
|
The symptoms, neurobiology, and current pharmacological treatment of depression.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;
ANTIDEPRESSANT AGENT;
MONOAMINE OXIDASE INHIBITOR;
NEUROTRANSMITTER RECEPTOR;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
AFFECT;
CLASSIFICATION;
DEPRESSION;
DRUG EFFECT;
DRUG INTERACTION;
HUMAN;
NEUROBIOLOGY;
PATIENT SELECTION;
PHYSIOLOGY;
PSYCHOLOGICAL ASPECT;
REVIEW;
TREATMENT OUTCOME;
AFFECT;
ANTIDEPRESSIVE AGENTS;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
DEPRESSIVE DISORDER;
DRUG INTERACTIONS;
HUMANS;
MONOAMINE OXIDASE INHIBITORS;
NEUROBIOLOGY;
NEUROTRANSMITTER AGENTS;
PATIENT SELECTION;
RECEPTORS, NEUROTRANSMITTER;
SEROTONIN UPTAKE INHIBITORS;
TREATMENT OUTCOME;
|
|
EID: 20444484553
PISSN: 08880395
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (28)
|
|
References (38)
|
